Veccia, Antonello
 Distribuzione geografica
Continente #
AS - Asia 85
NA - Nord America 58
EU - Europa 38
SA - Sud America 3
AF - Africa 2
Totale 186
Nazione #
US - Stati Uniti d'America 55
IT - Italia 34
SG - Singapore 18
BD - Bangladesh 14
CN - Cina 14
VN - Vietnam 13
HK - Hong Kong 11
KR - Corea 4
IN - India 3
CA - Canada 2
FI - Finlandia 2
IQ - Iraq 2
AR - Argentina 1
BB - Barbados 1
BR - Brasile 1
EC - Ecuador 1
EG - Egitto 1
FR - Francia 1
ID - Indonesia 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
PK - Pakistan 1
SA - Arabia Saudita 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 186
Città #
Trento 17
Singapore 13
Hong Kong 11
San Jose 8
Council Bluffs 6
Santa Clara 5
Hanoi 4
New York 4
Seoul 4
Wuxi 4
Milan 3
Portland 3
Ashburn 2
Baghdad 2
Buffalo 2
Da Nang 2
Helsinki 2
Ho Chi Minh City 2
Houston 2
Los Angeles 2
Ogden 2
Sellersburg 2
Adel 1
Alexandria 1
Atlanta 1
Bari 1
Batu Ampar 1
Beijing 1
Boardman 1
Bologna 1
Bridgetown 1
Casavatore 1
Castel Guelfo di Bologna 1
Cincinnati 1
Detroit 1
Fredericton 1
Genoa 1
Giza 1
Hyderabad 1
Istanbul 1
Kanpur 1
Kenosha 1
Lakewood 1
Lawrenceville 1
Lucca 1
Macerata 1
Manassas 1
Mazzè 1
Medina 1
Miano 1
Multan 1
Naples 1
Niceville 1
Port Harcourt 1
Province of Macerata 1
Quito 1
Rio de Janeiro 1
Rome 1
San Francisco 1
Santiago del Estero 1
Secaucus 1
Skopje 1
Tashkent 1
Thrissur 1
Toronto 1
Vĩnh Long 1
Totale 146
Nome #
Osimertinib in the Treatment of Epidermal Growth Factor Receptor-Mutant Early and Locally Advanced Stages of Non-Small-Cell Lung Cancer: Current Evidence and Future Perspectives 55
Development and Validation of Prognostic Model for Metastatic Castration-Resistant Prostate Cancer Patients Treated With First-Line Abiraterone or Enzalutamide 32
Association of G8 screening tool with prognosis and survival in patients with non-small cell lung cancer: A retrospective analysis from a single institution 27
Prognostic Role of Inflammatory and Nutritional Biomarkers in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors Alone or in Combination with Chemotherapy as First-Line 24
Prognostic factors of long-term response to androgen receptor signaling inhibitors used as first-line treatment for mCRPC 22
Organized prostate cancer screening program: a proposal from the Italian Society of Urology (SIU) 21
Prostate cancer: Screening and early detection 14
Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone 9
Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients 3
Docetaxel rechallenge in patients with castration-resistant prostate cancer - A review 3
Totale 210
Categoria #
all - tutte 664
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 664


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026202 0 0 0 0 0 0 0 1 93 55 17 36
2026/20278 8 0 0 0 0 0 0 0 0 0 0 0
Totale 210